GridAI Technologies (GRDX) Research & Development (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Research & Development came in at $8424.0 in Q2 2026, down 20.76% on a YoY basis from $10631.0 in Q2 2025, and down 99.06% quarter-over-quarter from $895673.0 in Q4 2025.
Analysis
GridAI Technologies (GRDX) Research & Development (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Research & Development for 12 consecutive years, with $8424.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development fell 20.76% year-over-year to $8424.0; the trailing twelve-month figure through Jun 2026 stood at $921401.0 (up 261.51% YoY), and the FY2025 full-year result was $927753.0, up 2.63% from the prior year.
- Research & Development fell to $8424.0 in Q2 2026 per GRDX's latest filing, from $895673.0 in the prior quarter.
- Across five years, Research & Development topped out at $5.0 million in Q1 2022 and bottomed at $6673.0 in Q3 2025.
- Historically, Research & Development has averaged $926436.4 across 5 years, with a median of $554662.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Research & Development plunged 98.36% in 2024, then surged 4081.68% in 2025.
- Over 5 years, Research & Development stood at $101822.0 in 2022, then surged by 1183.99% to $1.3 million in 2023, then slumped by 98.36% to $21419.0 in 2024, then soared by 4081.68% to $895673.0 in 2025, then plunged by 99.06% to $8424.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $8424.0, $895673.0, and $6673.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 1.87 Bn |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | 1.76 Bn |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | 993.80 Mn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 1.63 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | -486.00 Mn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | 651.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 529.60 Mn |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | 202.02 Mn |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 | 8,424.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,424.00 |
| Dec 31, 2025 | 895,673.00 |
| Sep 30, 2025 | 6,673.00 |
| Jun 30, 2025 | 10,631.00 |
| Mar 31, 2025 | 15,827.00 |
| Dec 31, 2024 | 21,419.00 |
| Sep 30, 2024 | 206,999.00 |
| Jun 30, 2024 | 219,591.00 |
| Mar 31, 2024 | 554,662.00 |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 101,822.00 |
| Sep 30, 2022 | 791,067.00 |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 3.05 Mn |
| Jun 30, 2021 | 5.65 Mn |